Fountainhead AM’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Fountainhead AM's BMY Position: Q3 2026 in Review
Fountainhead AM sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 46 shares — an estimated $2.66K sold.
Fountainhead AM first reported a position in BMY in Q4 2020 and held it in 23 quarters. The position peaked at $1.46M in Q1 2021. 2,414 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Fountainhead AM reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
- Fountainhead AM sold 46 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.66K.
- Fountainhead AM first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 23 quarters.
- Fountainhead AM's Bristol-Myers Squibb position peaked at $1.46M in Q1 2021.
- 2,414 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Fountainhead AM's 13F filing for Q3 2026, filed 5 Nov 2026.